Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$22,743,307
-$77,683 QoQ
Shares Held
62,806
-3.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#354
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $360,428,859 across 10 Drug Manufacturers - General names. AMGN ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,180 | $109,364,036 | |
| 2 | JNJ |
Johnson & Johnson
|
298,749 | $75,873,283 | |
| 3 | ABBV |
AbbVie Inc.
|
232,583 | $58,527,185 | |
| 4 | MRK |
Merck & Co., Inc.
|
299,881 | $38,534,708 | |
| 5 | AMGN |
Amgen Inc
This page
|
62,806 | $22,743,307 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
155,936 | $19,700,953 | |
| 7 | PFE |
Pfizer Inc
|
676,905 | $16,299,872 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
252,254 | $14,534,874 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,743,307 | 62,806 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $22,820,990 | 64,860 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $21,070,580 | 64,375 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $18,618,144 | 65,975 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $19,268,002 | 69,009 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $22,322,245 | 71,649 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $19,620,717 | 75,279 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $24,618,132 | 76,404 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $21,750,893 | 69,614 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $22,656,322 | 79,686 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $20,963,822 | 72,786 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $20,567,127 | 76,526 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $17,566,443 | 79,121 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $22,003,116 | 91,016 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $24,161,828 | 91,996 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $20,563,916 | 91,233 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $23,007,420 | 94,564 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $26,853,869 | 111,049 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $26,104,168 | 116,034 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $26,816,227 | 126,105 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $32,430,448 | 133,048 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $33,181,051 | 133,359 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $31,733,557 | 138,020 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $38,837,426 | 152,807 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $31,390,842 | 133,091 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $21,800,367 | 107,534 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||